Form4insider filings, from the source

SEC Form 4 · accession 0001012975-15-000772

Sage Therapeutics, Inc. · SAGE

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Kevin P Starr
Director · 10% Owner
Period of report
Nov 12, 2015
Accepted (ET)
Nov 13, 2015 · 4:46 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF2Nov 12, 2015J1,700,000$0.00D4,742,916ISee footnote
Common StockF4Nov 12, 2015J109,832$0.00A109,832ISee footnote
Common StockF4Nov 12, 2015J109,832$0.00D0ISee footnote
Common StockNov 12, 2015J15,986$0.00A65,227D

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses